Drug
Eprosartan clinical trials
Also written Teveten.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 4
Regional Hospital Holstebro (2) · Medical University of Lodz (1) · Abbott (1) · University of California, San Francisco (1) · Solvay Pharmaceuticals (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses eprosartan is read from its arms, and is right about nine times in ten.
Testing it · 6
- Effect of Losartan or Eprosartan on Fructose HyperuricemiaCompletedNot applicableMedical University of LodzNCT04954560Written as losartan and eprosartan
- Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential HypertensionCompletedPhase 3AbbottNCT01631227Written as Eprosartan
- Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy VolunteersCompletedPhase 1University of California, San FranciscoNCT01087749Written as Eprosartan
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNot applicableSolvay PharmaceuticalsNCT00160160Written as eprosartan/HCTZ
- The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential HypertensionCompletedPhase 4Regional Hospital HolstebroNCT00438945Written as Eprosartan
- The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.CompletedPhase 4Regional Hospital HolstebroNCT00409903Written as Eprosartan
Given in every arm · 1 — eprosartan is usual care beside what is tested
Codes
What other systems call eprosartan · ClinicalTrials.gg INT003563
- MeSH (NLM) C068373eprosartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2KH13Z0S0YEPROSARTANConfirmed FDA, NLM, Wikidata
- RxNorm 83515Confirmed FDA, Wikidata
- Wikidata Q784717eprosartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61749EprosartanOne source FDA
- DrugBank DB00876One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C068373 | eprosartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2KH13Z0S0Y | EPROSARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 83515 | — | Confirmed FDA, Wikidata |
| Wikidata | Q784717 | eprosartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61749 | Eprosartan | One source FDA |
| DrugBank | DB00876 | — | One source Wikidata |
Also registered as eprosartan mesylate (UNII 8N2L1NX8S3 · RxNorm 236878).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.